JAMA Oncology Author Interviews

Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: * New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.1285?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: * Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0756?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: * Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0236?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0130?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: * Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.7033?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: * Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.6168?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]